Longitudinal Cognitive Assessment by BoCA

ConditionsAlzheimer Disease Mild Cognitive Impairment Vascular Dementia Frontotemporal Dementia Parkinson Disease Multiple Sclerosis TBI

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age50+

SponsorAlzheimer's Light LLC

About this trial

The Boston Cognitive Assessment (BoCA) is a self-administered online test intended for longitudinal cognitive monitoring. BoCA uses random not-repeating tasks to minimize learning effects. BoCA was developed to evaluate the effects of treatment in longitudinal clinical trials and available gratis to individuals and professionals.

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

Boston Cognitive Assessment (BoCA)

Treatment groups

10,000 Participants

are divided into 8 treatment groups

Treatment groups

See each treatment group below.

Sponsors and collaborators

Alzheimer's Light LLC

Lead sponsor

Source ClinicalTrials.gov